Deborah S Usinger
Overview
Explore the profile of Deborah S Usinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen R, Basak R, Dusetzina S, Usinger D, Mohammed Z, Falchook A, et al.
JNCI Cancer Spectr
. 2024 Oct;
8(6).
PMID: 39383199
Background: Posttreatment surveillance affects millions of cancer survivors, but empiric data to guide clinical practice are lacking. This study assessed whether the intensity of surveillance testing after radical prostatectomy or...
2.
Chen L, Usinger D, Katz A
Cancer Med
. 2023 Jul;
12(16):17308-17312.
PMID: 37455582
Background: Reasons underlying disparities in telehealth use among cancer survivors are unknown. Methods: We surveyed a sociodemographically diverse population-based cohort of 487 prostate cancer survivors regarding their use and perceptions...
3.
Katz A, Chen R, Usinger D, Danus S, Zullig L
J Cancer Surviv
. 2022 Jul;
17(2):351-359.
PMID: 35790675
Purpose: Cardiovascular disease (CVD) is a common cause of mortality among men with prostate cancer. However, receipt of preventive care and management of pre-existent CVD has not been well studied...
4.
Basak R, Usinger D, Chen R, Shen X
JNCI Cancer Spectr
. 2022 Jun;
6(1).
PMID: 35699497
Background: Active surveillance (AS) is underutilized for low-risk prostate cancer. This study examines decision-making factors associated with AS vs aggressive treatment in a population-based cohort of low-risk patients. Methods: Newly...
5.
Chen R, Prime S, Basak R, Moon D, Liang C, Usinger D, et al.
Int J Radiat Oncol Biol Phys
. 2021 Jan;
110(3):712-715.
PMID: 33453308
Purpose: Prospective clinical trials have demonstrated the safety and efficacy of active surveillance for men with localized prostate cancer but also suggested that inadequate surveillance may risk missing an opportunity...
6.
Moon D, Basak R, Usinger D, Dickerson G, Morris D, Perman M, et al.
Eur Urol
. 2019 Mar;
76(3):391-397.
PMID: 30857758
Background: Evidence supporting the efficacy of stereotactic body radiotherapy (SBRT) for localized prostate cancer is accumulating, but comparative studies of patient-reported quality of life (QOL) following SBRT versus conventionally fractionated...
7.
Reeve B, Wang M, Weinfurt K, Flynn K, Usinger D, Chen R
J Sex Med
. 2018 Dec;
15(12):1792-1810.
PMID: 30539735
Background: There are multiple treatment options for men with localized prostate cancer that provide similar curative efficacy but differ in their impact on sexual functioning. Aim: To evaluate the psychometric...
8.
Reeve B, Tan X, Chen R, Usinger D, Pinheiro L
Cancer
. 2018 Apr;
124(13):2832-2840.
PMID: 29660795
Background: Men diagnosed with localized prostate cancer seek information on how treatment options may impact their health-related quality of life (HRQOL). The authors used latent profile analysis (LPA) to group...
9.
Broughman J, Basak R, Nielsen M, Reeve B, Usinger D, Spearman K, et al.
J Natl Cancer Inst
. 2017 Oct;
110(4):420-425.
PMID: 29045679
Background: Men with early-stage prostate cancer have multiple options that have similar oncologic efficacy but vary in terms of their impact on quality of life. In low-risk cancer, active surveillance...
10.
Wang M, Chen R, Usinger D, Reeve B
Qual Life Res
. 2017 Jul;
26(11):2973-2985.
PMID: 28681335
Purpose: To evaluate measurement invariance (phone interview vs computer self-administered survey) of 15 PROMIS measures responded by a population-based cohort of localized prostate cancer survivors. Methods: Participants were part of...